Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 630 of 1,261
  1. US 9662327

    Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer

    Agios Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  2. US 9662317

    Methods of administering tolperisone for therapeutic purposes

    SANOCHEMIA PHARMAZEUTIKA AG · Granted May 30, 2017 · Expires May 25, 2037

    granted
  3. US 9663783

    Modulation of alpha synuclein expression

    Ionis Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  4. US 9662312

    Method for treating glomerulosclerosis

    Ligand Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted
  5. US 9663585

    Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted May 30, 2017 · Expires May 25, 2037

    granted
  6. US 9663790

    Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted
  7. US 9663788

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted May 30, 2017 · Expires May 25, 2037

    granted
  8. US 9663564

    Vectors and methods to treat ischemia

    The Regents of the University of California · Granted May 30, 2017 · Expires May 25, 2037

    granted
  9. US 9663569

    Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted
  10. US 9663521

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted
  11. US 9663519

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted
  12. US 9663514

    Substituted 6-aza-isoindolin-1-one derivatives

    Takeda Pharmaceutical Company Limited · Granted May 30, 2017 · Expires May 25, 2037

    granted
  13. US 9663509

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted May 30, 2017 · Expires May 25, 2037

    granted
  14. US 9663498

    Aromatic heterocyclic compounds and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  15. US 9663493

    Pyridazine compounds, compositions and methods

    Northwestern University · Granted May 30, 2017 · Expires May 25, 2037

    granted
  16. US 9663485

    Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted
  17. US 9663496

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  18. US 9663481

    Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

    VTV THERAPEUTICS LLC · Granted May 30, 2017 · Expires May 25, 2037

    granted
  19. US 9663468

    2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

    Northwestern University · Granted May 30, 2017 · Expires May 25, 2037

    granted
  20. US 9662377

    Therapeutic composition for treatment of glioblastoma

    Regents of the University of Minnesota · Granted May 30, 2017 · Expires May 25, 2037

    granted
  21. US 9662396

    Stable aqueous formulations of etanercept

    Coherus BioSciences, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  22. US 9662414

    Dressing system

    FIRST WATER LIMITED · Granted May 30, 2017 · Expires May 25, 2037

    granted
  23. US 9662393

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  24. US 9662350

    Pharmaceutical composition and method for inhibiting inflammation

    China Medical University · Granted May 30, 2017 · Expires May 25, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.